Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Report 2021

Publisher Name :
Date: 06-May-2021
No. of pages: 141
Inquire Before Buying

The global Measles, Mumps and Rubella (MMR) Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Measles, Mumps and Rubella (MMR) Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type

- Monovalent Vaccine

- Polyvalent Vaccine

Segment by Application

- Immune Center

- Vaccine Development Agencies and Organizations

- Hospital

- Laboratory

- Biotechnology and Biopharmaceutical Companies

The Measles, Mumps and Rubella (MMR) Vaccines market is analysed and market size information is provided by regions (countries). Segment by Application, the Measles, Mumps and Rubella (MMR) Vaccines market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company

- Medlmmune

- Johnson & Johnson

- Merck

- Sanofi

- Serum

- Bavarian Nordic

- Astellas Pharma

- Emergent BioSolutions

- GlaxoSmithKline

- Pfizer

- CSL

Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Report 2021

Table of Contents
1 Measles, Mumps and Rubella (MMR) Vaccines Market Overview
1.1 Measles, Mumps and Rubella (MMR) Vaccines Product Scope
1.2 Measles, Mumps and Rubella (MMR) Vaccines Segment by Type
1.2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2016 & 2021 & 2027)
1.2.2 Monovalent Vaccine
1.2.3 Polyvalent Vaccine
1.3 Measles, Mumps and Rubella (MMR) Vaccines Segment by Application
1.3.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Immune Center
1.3.3 Vaccine Development Agencies and Organizations
1.3.4 Hospital
1.3.5 Laboratory
1.3.6 Biotechnology and Biopharmaceutical Companies
1.4 Measles, Mumps and Rubella (MMR) Vaccines Market Estimates and Forecasts (2016-2027)
1.4.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Measles, Mumps and Rubella (MMR) Vaccines Price Trends (2016-2027)
2 Measles, Mumps and Rubella (MMR) Vaccines Estimates and Forecasts by Region
2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region (2016-2021)
2.2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region (2016-2021)
2.3 Global Measles, Mumps and Rubella (MMR) Vaccines Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Measles, Mumps and Rubella (MMR) Vaccines Estimates and Projections (2016-2027)
2.4.2 Europe Measles, Mumps and Rubella (MMR) Vaccines Estimates and Projections (2016-2027)
2.4.3 China Measles, Mumps and Rubella (MMR) Vaccines Estimates and Projections (2016-2027)
2.4.4 Japan Measles, Mumps and Rubella (MMR) Vaccines Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Estimates and Projections (2016-2027)
2.4.6 India Measles, Mumps and Rubella (MMR) Vaccines Estimates and Projections (2016-2027)
3 Global Measles, Mumps and Rubella (MMR) Vaccines Competition Landscape by Players
3.1 Global Top Measles, Mumps and Rubella (MMR) Vaccines Players by Sales (2016-2021)
3.2 Global Top Measles, Mumps and Rubella (MMR) Vaccines Players by Revenue (2016-2021)
3.3 Global Measles, Mumps and Rubella (MMR) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Measles, Mumps and Rubella (MMR) Vaccines as of 2020)
3.4 Global Measles, Mumps and Rubella (MMR) Vaccines Average Price by Company (2016-2021)
3.5 Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size by Type
4.1 Global Measles, Mumps and Rubella (MMR) Vaccines Historic Market Review by Type (2016-2021)
4.1.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2016-2021)
4.1.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Type (2016-2021)
4.1.3 Global Measles, Mumps and Rubella (MMR) Vaccines Price by Type (2016-2021)
4.2 Global Measles, Mumps and Rubella (MMR) Vaccines Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Global Measles, Mumps and Rubella (MMR) Vaccines Price Forecast by Type (2022-2027)
5 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size by Application
5.1 Global Measles, Mumps and Rubella (MMR) Vaccines Historic Market Review by Application (2016-2021)
5.1.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2016-2021)
5.1.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Application (2016-2021)
5.1.3 Global Measles, Mumps and Rubella (MMR) Vaccines Price by Application (2016-2021)
5.2 Global Measles, Mumps and Rubella (MMR) Vaccines Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Global Measles, Mumps and Rubella (MMR) Vaccines Price Forecast by Application (2022-2027)
6 North America Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures
6.1 North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Company
6.1.1 North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Company (2016-2021)
6.1.2 North America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Company (2016-2021)
6.2 North America Measles, Mumps and Rubella (MMR) Vaccines Sales Breakdown by Type
6.2.1 North America Measles, Mumps and Rubella (MMR) Vaccines Sales Breakdown by Type (2016-2021)
6.2.2 North America Measles, Mumps and Rubella (MMR) Vaccines Sales Breakdown by Type (2022-2027)
6.3 North America Measles, Mumps and Rubella (MMR) Vaccines Sales Breakdown by Application
6.3.1 North America Measles, Mumps and Rubella (MMR) Vaccines Sales Breakdown by Application (2016-2021)
6.3.2 North America Measles, Mumps and Rubella (MMR) Vaccines Sales Breakdown by Application (2022-2027)
7 Europe Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures
7.1 Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Company
7.1.1 Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Company (2016-2021)
7.1.2 Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue by Company (2016-2021)
7.2 Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Breakdown by Type
7.2.1 Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Breakdown by Type (2016-2021)
7.2.2 Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Breakdown by Type (2022-2027)
7.3 Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Breakdown by Application
7.3.1 Europe 141 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 141 Sales Breakdown by Application (2022-2027)
8 China Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures
8.1 China Measles, Mumps and Rubella (MMR) Vaccines Sales by Company
8.1.1 China Measles, Mumps and Rubella (MMR) Vaccines Sales by Company (2016-2021)
8.1.2 China Measles, Mumps and Rubella (MMR) Vaccines Revenue by Company (2016-2021)
8.2 China Measles, Mumps and Rubella (MMR) Vaccines Sales Breakdown by Type
8.2.1 China Measles, Mumps and Rubella (MMR) Vaccines Sales Breakdown by Type (2016-2021)
8.2.2 China Measles, Mumps and Rubella (MMR) Vaccines Sales Breakdown by Type (2022-2027)
8.3 China Measles, Mumps and Rubella (MMR) Vaccines Sales Breakdown by Application
8.3.1 China 318 Sales Breakdown by Application (2016-2021)
8.3.2 China 318 Sales Breakdown by Application (2022-2027)
9 Japan Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures
9.1 Japan Measles, Mumps and Rubella (MMR) Vaccines Sales by Company
9.1.1 Japan Measles, Mumps and Rubella (MMR) Vaccines Sales by Company (2016-2021)
9.1.2 Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue by Company (2016-2021)
9.2 Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Breakdown by Type
9.2.1 Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Breakdown by Type (2016-2021)
9.2.2 Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Breakdown by Type (2022-2027)
9.3 Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures
10.1 Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales by Company
10.1.1 Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales by Company (2016-2021)
10.1.2 Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Revenue by Company (2016-2021)
10.2 Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales Breakdown by Type
10.2.1 Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales Breakdown by Application
10.3.1 Southeast Asia K Doses Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Doses Sales Breakdown by Application (2022-2027)
11 India Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures
11.1 India Measles, Mumps and Rubella (MMR) Vaccines Sales by Company
11.1.1 India Measles, Mumps and Rubella (MMR) Vaccines Sales by Company (2016-2021)
11.1.2 India Measles, Mumps and Rubella (MMR) Vaccines Revenue by Company (2016-2021)
11.2 India Measles, Mumps and Rubella (MMR) Vaccines Sales Breakdown by Type
11.2.1 India Measles, Mumps and Rubella (MMR) Vaccines Sales Breakdown by Type (2016-2021)
11.2.2 India Measles, Mumps and Rubella (MMR) Vaccines Sales Breakdown by Type (2022-2027)
11.3 India Measles, Mumps and Rubella (MMR) Vaccines Sales Breakdown by Application
11.3.1 India Measles, Mumps and Rubella (MMR) Vaccines Sales Breakdown by Application (2016-2021)
11.3.2 India Measles, Mumps and Rubella (MMR) Vaccines Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Measles, Mumps and Rubella (MMR) Vaccines Business
12.1 Medlmmune
12.1.1 Medlmmune Corporation Information
12.1.2 Medlmmune Business Overview
12.1.3 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.1.5 Medlmmune Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Corporation Information
12.2.2 Johnson & Johnson Business Overview
12.2.3 Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.2.5 Johnson & Johnson Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Business Overview
12.3.3 Merck Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.3.5 Merck Recent Development
12.4 Sanofi
12.4.1 Sanofi Corporation Information
12.4.2 Sanofi Business Overview
12.4.3 Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sanofi Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.4.5 Sanofi Recent Development
12.5 Serum
12.5.1 Serum Corporation Information
12.5.2 Serum Business Overview
12.5.3 Serum Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Serum Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.5.5 Serum Recent Development
12.6 Bavarian Nordic
12.6.1 Bavarian Nordic Corporation Information
12.6.2 Bavarian Nordic Business Overview
12.6.3 Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.6.5 Bavarian Nordic Recent Development
12.7 Astellas Pharma
12.7.1 Astellas Pharma Corporation Information
12.7.2 Astellas Pharma Business Overview
12.7.3 Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.7.5 Astellas Pharma Recent Development
12.8 Emergent BioSolutions
12.8.1 Emergent BioSolutions Corporation Information
12.8.2 Emergent BioSolutions Business Overview
12.8.3 Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.8.5 Emergent BioSolutions Recent Development
12.9 GlaxoSmithKline
12.9.1 GlaxoSmithKline Corporation Information
12.9.2 GlaxoSmithKline Business Overview
12.9.3 GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.9.4 GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.9.5 GlaxoSmithKline Recent Development
12.10 Pfizer
12.10.1 Pfizer Corporation Information
12.10.2 Pfizer Business Overview
12.10.3 Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Pfizer Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.10.5 Pfizer Recent Development
12.11 CSL
12.11.1 CSL Corporation Information
12.11.2 CSL Business Overview
12.11.3 CSL Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.11.4 CSL Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.11.5 CSL Recent Development
13 Measles, Mumps and Rubella (MMR) Vaccines Manufacturing Cost Analysis
13.1 Measles, Mumps and Rubella (MMR) Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Measles, Mumps and Rubella (MMR) Vaccines
13.4 Measles, Mumps and Rubella (MMR) Vaccines Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Measles, Mumps and Rubella (MMR) Vaccines Distributors List
14.3 Measles, Mumps and Rubella (MMR) Vaccines Customers
15 Market Dynamics
15.1 Measles, Mumps and Rubella (MMR) Vaccines Market Trends
15.2 Measles, Mumps and Rubella (MMR) Vaccines Drivers
15.3 Measles, Mumps and Rubella (MMR) Vaccines Market Challenges
15.4 Measles, Mumps and Rubella (MMR) Vaccines Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Measles, Mumps and Rubella (MMR) Vaccines Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Region (2016-2021)
Table 5. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region (2016-2021)
Table 6. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Region (2016-2021)
Table 8. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) Forecast by Region (2022-2027)
Table 9. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share Forecast by Region (2022-2027)
Table 12. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) of Key Companies (2016-2021)
Table 13. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Company (2016-2021)
Table 14. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Company (2016-2021)
Table 16. Global Measles, Mumps and Rubella (MMR) Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Measles, Mumps and Rubella (MMR) Vaccines as of 2020)
Table 17. Global Measles, Mumps and Rubella (MMR) Vaccines Average Price (USD/Dose) of Key Company (2016-2021)
Table 18. Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Manufacturing Sites and Area Served
Table 19. Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Type (2016-2021)
Table 22. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Type (2016-2021)
Table 23. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Measles, Mumps and Rubella (MMR) Vaccines Price (USD/Dose) by Type (2016-2021)
Table 25. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Type (2022-2027)
Table 26. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Type (2022-2027)
Table 28. Global Measles, Mumps and Rubella (MMR) Vaccines Price (USD/Dose) by Type (2022-2027)
Table 29. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Application (2016-2021)
Table 30. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Application (2016-2021)
Table 31. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Measles, Mumps and Rubella (MMR) Vaccines Price (USD/Dose) by Application (2016-2021)
Table 33. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Application (2022-2027)
Table 34. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Application (2022-2027)
Table 35. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Application (2022-2027)
Table 37. Global Measles, Mumps and Rubella (MMR) Vaccines Price (USD/Dose) by Application (2022-2027)
Table 38. North America Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Company (2016-2021)
Table 39. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Company (2016-2021)
Table 40. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Company (2016-2021)
Table 42. North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2016-2021) & (K Doses)
Table 43. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2016-2021)
Table 44. North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2022-2027) & (K Doses)
Table 45. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2022-2027)
Table 46. North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2016-2021) & (K Doses)
Table 47. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2016-2021)
Table 48. North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2022-2027) & (K Doses)
Table 49. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2022-2027)
Table 50. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Company (2016-2021)
Table 51. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Company (2016-2021)
Table 52. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Company (2016-2021)
Table 54. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2016-2021) & (K Doses)
Table 55. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2016-2021)
Table 56. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2022-2027) & (K Doses)
Table 57. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2022-2027)
Table 58. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2016-2021) & (K Doses)
Table 59. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2016-2021)
Table 60. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2022-2027) & (K Doses)
Table 61. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2022-2027)
Table 62. China Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Company (2016-2021)
Table 63. China Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Company (2016-2021)
Table 64. China Measles, Mumps and Rubella (MMR) Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Company (2016-2021)
Table 66. China Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2016-2021) & (K Doses)
Table 67. China Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2016-2021)
Table 68. China Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2022-2027) & (K Doses)
Table 69. China Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2022-2027)
Table 70. China Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2016-2021) & (K Doses)
Table 71. China Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2016-2021)
Table 72. China Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2022-2027) & (K Doses)
Table 73. China Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2022-2027)
Table 74. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Company (2016-2021)
Table 75. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Company (2016-2021)
Table 76. Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Company (2016-2021)
Table 78. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2016-2021) & (K Doses)
Table 79. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2016-2021)
Table 80. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2022-2027) & (K Doses)
Table 81. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2022-2027)
Table 82. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2016-2021) & (K Doses)
Table 83. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2016-2021)
Table 84. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2022-2027) & (K Doses)
Table 85. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Company (2016-2021)
Table 87. Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2016-2021) & (K Doses)
Table 91. Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2022-2027) & (K Doses)
Table 93. Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2016-2021) & (K Doses)
Table 95. Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2022-2027) & (K Doses)
Table 97. Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2022-2027)
Table 98. India Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Company (2016-2021)
Table 99. India Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Company (2016-2021)
Table 100. India Measles, Mumps and Rubella (MMR) Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Company (2016-2021)
Table 102. India Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2016-2021) & (K Doses)
Table 103. India Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2016-2021)
Table 104. India Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2022-2027) & (K Doses)
Table 105. India Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2022-2027)
Table 106. India Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2016-2021) & (K Doses)
Table 107. India Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2016-2021)
Table 108. India Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2022-2027) & (K Doses)
Table 109. India Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2022-2027)
Table 110. Medlmmune Corporation Information
Table 111. Medlmmune Description and Business Overview
Table 112. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 113. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Product
Table 114. Medlmmune Recent Development
Table 115. Johnson & Johnson Corporation Information
Table 116. Johnson & Johnson Description and Business Overview
Table 117. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 118. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Product
Table 119. Johnson & Johnson Recent Development
Table 120. Merck Corporation Information
Table 121. Merck Description and Business Overview
Table 122. Merck Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 123. Merck Measles, Mumps and Rubella (MMR) Vaccines Product
Table 124. Merck Recent Development
Table 125. Sanofi Corporation Information
Table 126. Sanofi Description and Business Overview
Table 127. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 128. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Product
Table 129. Sanofi Recent Development
Table 130. Serum Corporation Information
Table 131. Serum Description and Business Overview
Table 132. Serum Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 133. Serum Measles, Mumps and Rubella (MMR) Vaccines Product
Table 134. Serum Recent Development
Table 135. Bavarian Nordic Corporation Information
Table 136. Bavarian Nordic Description and Business Overview
Table 137. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 138. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Product
Table 139. Bavarian Nordic Recent Development
Table 140. Astellas Pharma Corporation Information
Table 141. Astellas Pharma Description and Business Overview
Table 142. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 143. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Product
Table 144. Astellas Pharma Recent Development
Table 145. Emergent BioSolutions Corporation Information
Table 146. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 147. Emergent BioSolutions Description and Business Overview
Table 148. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Product
Table 149. Emergent BioSolutions Recent Development
Table 150. GlaxoSmithKline Corporation Information
Table 151. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 152. GlaxoSmithKline Description and Business Overview
Table 153. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Product
Table 154. GlaxoSmithKline Recent Development
Table 155. Pfizer Corporation Information
Table 156. Pfizer Description and Business Overview
Table 157. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 158. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Product
Table 159. Pfizer Recent Development
Table 160. CSL Corporation Information
Table 161. CSL Description and Business Overview
Table 162. CSL Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 163. CSL Measles, Mumps and Rubella (MMR) Vaccines Product
Table 164. CSL Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Measles, Mumps and Rubella (MMR) Vaccines Distributors List
Table 168. Measles, Mumps and Rubella (MMR) Vaccines Customers List
Table 169. Measles, Mumps and Rubella (MMR) Vaccines Market Trends
Table 170. Measles, Mumps and Rubella (MMR) Vaccines Market Drivers
Table 171. Measles, Mumps and Rubella (MMR) Vaccines Market Challenges
Table 172. Measles, Mumps and Rubella (MMR) Vaccines Market Restraints
Table 173.
  • Global Prenatal Vitamin Ingredients Sales Market Report 2021
    Published: 11-Jun-2021        Price: US 4000 Onwards        Pages: 146
    Market Analysis and Insights: Global Prenatal Vitamin Ingredients Market The global Prenatal Vitamin Ingredients market was valued at US$ 51370 in 2020 and will reach US$ 63150 million by the end of 2027, growing at a CAGR of 3.5% during 2022-2027. Global Prenatal Vitamin Ingredients Scope and Market Size The global Prenatal Vitamin Ingredients market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants......
  • Global Specialty Supplements Sales Market Report 2021
    Published: 11-Jun-2021        Price: US 4000 Onwards        Pages: 144
    A specialty supplement is a formula that has been specially designed to support a specific structure/function application in the body - such as joint health and immune support. Some are single-ingredient products. Others are combination formulas, providing unique blends of complementary ingredients that scientific research has shown work synergistically in the body to illicit similar pharmacological effects. Market Analysis and Insights: Global Specialty Supplements Market ......
  • Global Letter Vitamins Sales Market Report 2021
    Published: 11-Jun-2021        Price: US 4000 Onwards        Pages: 148
    A vitamin is an organic molecule (or related set of molecules) that is an essential micronutrient that an organism needs in small quantities for the proper functioning of its metabolism. Essential nutrients cannot be synthesized in the organism, either at all or not in sufficient quantities, and therefore must be obtained through the diet. Vitamin C can be synthesized by some species but not by others; it is not a vitamin in the first instance but is in the second. Market Analysis......
  • Global Curcuminoid Sales Market Report 2021
    Published: 11-Jun-2021        Price: US 4000 Onwards        Pages: 142
    Market Analysis and Insights: Global Curcuminoid Market The global Curcuminoid market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Curcuminoid Scope and Market Size The global Curcuminoid market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Curcuminoid market will be able to gain the upper hand as th......
  • Global Pet Medicine Sales Market Report 2021
    Published: 11-Jun-2021        Price: US 4000 Onwards        Pages: 136
    Well over half of the triplicate in the United States own a pet -- almost 80 million homes!Man 's best friend took a be the most iconic. But it' s been a dog, cat, horse, bird, fish, or lizard, pets need to be cared for, pet medical is required. Market Analysis and Insights: Global Pet Medicine Market The global Pet Medicine market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global ......
  • Global Large Volume Parenteral (LVP) Market Insights and Forecast to 2027
    Published: 11-Jun-2021        Price: US 4900 Onwards        Pages: 148
    Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered. Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be adm......
  • Global Seaweed Powder Market Insights and Forecast to 2027
    Published: 11-Jun-2021        Price: US 4900 Onwards        Pages: 118
    Seaweed powder is made from marine natural seaweed, supplemented by a small amount of marine microalgae. Natural seaweed powder is rich in seaweed polysaccharides, mannitol, amino acids, proteins, vitamins and potassium, iron, calcium, phosphorus, iodine, selenium, cobalt and other trace elements. The global seaweed powder market is dominated by the Asia Pacific region, and North America is the second largest regional market. At present, the main manufacturers of seaweed powder are ......
  • Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Insights and Forecast to 2027
    Published: 11-Jun-2021        Price: US 4900 Onwards        Pages: 111
    Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. The classification of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs includes 5-HT3 Inhibitors, NK1 Inhibitors and others. The proportion of 5-HT3 Inhibitors in 2017 is about 62%, and the proportion of NK1 Inhibitors in 2017 is about 33%. Market A......
  • Global Cell Culture Protein Surface Coatings Market Insights and Forecast to 2027
    Published: 11-Jun-2021        Price: US 4900 Onwards        Pages: 115
    The cell culture protein surface coating is a technique in which the cell culture surfaces are coated with extracellular matrix or proteins components to improve the proliferation and adhesion of the cells in vitro. In the last several years, global market of Cell Culture Protein Surface Coatings developed rapidly, with an average growth rate of 13.7%. Market Analysis and Insights: Global Cell Culture Protein Surface Coatings Market The global Cell Culture Protein Su......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs